These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38259493)

  • 61. Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis.
    Zhang B; Gao D; Xu G; Zhu W; Liu J; Sun R; Wang L; Zhang C; Ding Q; Shi Y
    Phytochem Anal; 2022 Jul; 33(5):678-695. PubMed ID: 35396886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis.
    Zeng Y; Huang J; Guo R; Cao S; Yang H; Ouyang W
    Front Genet; 2023; 14():1058582. PubMed ID: 36923791
    [No Abstract]   [Full Text] [Related]  

  • 63. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis.
    Yuan S; Zuo B; Zhou SC; Wang M; Tan KY; Chen ZW; Cao WF
    Drug Des Devel Ther; 2023; 17():1289-1302. PubMed ID: 37138582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
    Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
    Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway.
    Huang X; He Y; Chen Y; Wu P; Gui D; Cai H; Chen A; Chen M; Dai C; Yao D; Wang L
    BMC Pulm Med; 2016 Sep; 16(1):132. PubMed ID: 27658704
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206
    Wang J; Xu L; Xiang Z; Ren Y; Zheng X; Zhao Q; Zhou Q; Zhou Y; Xu L; Wang Y
    Cell Death Dis; 2020 Feb; 11(2):136. PubMed ID: 32075954
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
    Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
    J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
    Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis.
    Wan X; Tian X; Du J; Lu Y; Xiao Y
    Respir Res; 2020 Nov; 21(1):290. PubMed ID: 33138822
    [TBL] [Abstract][Full Text] [Related]  

  • 71. AAV9-Tspyl2 gene therapy retards bleomycin-induced pulmonary fibrosis by modulating downstream TGF-β signaling in mice.
    Zhang S; Tong X; Liu S; Huang J; Zhang L; Zhang T; Wang D; Fan H
    Cell Death Dis; 2023 Jun; 14(6):389. PubMed ID: 37391440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Total flavonoids of Oxytropis falcata Bunge have a positive effect on idiopathic pulmonary fibrosis by inhibiting the TGF-β1/Smad signaling pathway.
    Li XZ; Wang XL; Wang YJ; Liang QK; Li Y; Chen YW; Ming HX
    J Ethnopharmacol; 2022 Mar; 285():114858. PubMed ID: 34826543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

  • 76. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis.
    Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L
    Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling.
    Zhang J; Zhang Y; Chen Q; Qi Y; Zhang X
    Int Immunopharmacol; 2024 Mar; 130():111734. PubMed ID: 38422768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
    Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL
    Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
    Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
    Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic potential of ADSC-EV-derived lncRNA DLEU2: A novel molecular pathway in alleviating sepsis-induced lung injury via the miR-106a-5p/LXN axis.
    He W; Xu C; Huang Y; Zhang Q; Chen W; Zhao C; Chen Y; Zheng D; XinyueLin ; Luo Q; Chen X; Zhang Z; Wu X; Huang J; Lin C; Huang Y; Zhang S
    Int Immunopharmacol; 2024 Mar; 130():111519. PubMed ID: 38442573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.